These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15218329)

  • 1. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
    Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
    Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine: a false dawn in the treatment of muscle weakness in end-stage renal failure patients?
    Davenport A
    Nephron Clin Pract; 2004; 97(2):c33-4. PubMed ID: 15218327
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
    Thompson CH; Irish AB; Kemp GJ; Taylor DJ; Radda GK
    Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
    Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
    Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.
    Tarnopolsky M; Mahoney D; Thompson T; Naylor H; Doherty TJ
    Muscle Nerve; 2004 Jan; 29(1):51-8. PubMed ID: 14694498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
    Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
    Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
    Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
    Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
    Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
    Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo.
    Kemp GJ; Crowe AV; Anijeet HK; Gong QY; Bimson WE; Frostick SP; Bone JM; Bell GM; Roberts JN
    Nephrol Dial Transplant; 2004 Jun; 19(6):1520-7. PubMed ID: 15004250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.
    Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M
    Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired muscle oxygen metabolism in uremic children: improved after renal transplantation.
    Matsumoto N; Ichimura S; Hamaoka T; Osada T; Hattori M; Miyakawa S
    Am J Kidney Dis; 2006 Sep; 48(3):473-80. PubMed ID: 16931221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle metabolism before and after gemfibrozil treatment in dialysed patients with chronic renal failure.
    Thompson CH; Irish A; Kemp GJ; Taylor DJ; Radda GK
    Clin Nephrol; 1996 Jun; 45(6):386-9. PubMed ID: 8793231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uraemic muscle metabolism at rest and during exercise.
    Thompson CH; Kemp GJ; Barnes PR; Rajagopalan B; Styles P; Taylor DJ; Radda GK
    Nephrol Dial Transplant; 1994; 9(11):1600-5. PubMed ID: 7870350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
    Jucker BM; Yang D; Casey WM; Olzinski AR; Williams C; Lenhard SC; Legos JJ; Hawk CT; Sarkar SK; Newsholme SJ
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1256-64. PubMed ID: 17726146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine replacement in end-stage renal disease and hemodialysis.
    Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
    Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prolonged L-carnitine administration on delayed muscle pain and CK release after eccentric effort.
    Giamberardino MA; Dragani L; Valente R; Di Lisa F; Saggini R; Vecchiet L
    Int J Sports Med; 1996 Jul; 17(5):320-4. PubMed ID: 8858401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of nocturnal haemodialysis on carnitine metabolism.
    Hothi DK; Geary DF; Fisher L; Chan CT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2637-41. PubMed ID: 16822785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: A double-blind randomized trial.
    Thomas S; Fischer FP; Mettang T; Pauli-Magnus C; Weber J; Kuhlmann U
    Am J Kidney Dis; 1999 Oct; 34(4):678-87. PubMed ID: 10516349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.